Exact Mass: 211.1235

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

ISOURON

3-(5-(TERT-BUTYL)ISOXAZOL-3-YL)-1,1-DIMETHYLUREA

Isoproterenol

4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol

Isoproterenol is only found in individuals that have used or taken this drug. It is an isopropyl analog of epinephrine; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. [PubChem]The pharmacologic effects of isoproterenol are at least in part attributable to stimulation through beta-adrenergic receptors of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic AMP. Increased cyclic AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

Orciprenaline

5-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,3-diol

Orciprenaline is only found in individuals that have used or taken this drug. It is a beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]Orciprenaline is a moderately selective beta(2)-adrenergic agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on alpha-adrenergic receptors. Intracellularly, the actions of orciprenaline are mediated by cAMP, the production of which is augmented by beta stimulation. The drug is believed to work by activating adenylate cyclase, the enzyme responsible for producing the cellular mediator cAMP. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents

Methoxamine

Glaxo wellcome brand 1 OF methoxamine hydrochloride

Methoxamine is only found in individuals that have used or taken this drug. It is an alpha-adrenergic agonist that causes prolonged peripheral vasoconstriction. It has little if any direct effect on the central nervous system. [PubChem]Methoxamine acts through peripheral vasoconstriction by acting as a pure alpha-1 adrenergic receptor agonist, consequently increasing systemic blood pressure (both systolic and diastolic). C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents KEIO_ID M169; [MS2] KO009056 KEIO_ID M169

Pramipexole

6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate

Pramipexole is a medication indicated for treating Parkinsons disease and restless legs syndrome (RLS). It is also sometimes used off-label as a treatment for cluster headache or to counteract the problems with low libido experienced by some users of SSRI antidepressant drugs. Pramipexole has shown robust effects on pilot studies in bipolar disorder. Pramipexole is classified as a non-ergoline dopamine agonist. D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D020011 - Protective Agents > D000975 - Antioxidants Pramipexole is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].

Dexpramipexole

6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate

(9Z)-12-oxo-dodec-9-enoate

(9Z)-12-oxo-Dodec-9-enoic acid

C12H19O3 (211.1334)

(9z)-12-oxo-dodec-9-enoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9z)-12-oxo-dodec-9-enoate can be found in a number of food items such as abiyuch, butternut squash, prickly pear, and garden tomato (variety), which makes (9z)-12-oxo-dodec-9-enoate a potential biomarker for the consumption of these food products.

methyl 2,2-dimethyl-3-[3-(hydroxyimino)-2-methyl-1-propenyl)-cyclopropanecarboxylate

C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

Pramipexole

(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D020011 - Protective Agents > D000975 - Antioxidants Pramipexole is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].

mescaline

A phenethylamine alkaloid that is phenethylamine substituted at positions 3, 4 and 5 by methoxy groups. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

Isoprenaline

isoproterenol

4-(azepan-1-ylmethyl)-1,3-thiazol-2-amine

dioxethedrin

C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent

1-(4-Aminophenoxy)-3-ethoxy-2-propanol

5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate

tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

tert-butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

4-(2,4-Difluorobenzyl)piperidine

C12H15F2N (211.1172)

Dexpramipexole

D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D020011 - Protective Agents > D000975 - Antioxidants

4-Cyanopiperazine-1-Carboxylic Acid Tert-Butyl Ester

1-(cyclobutanecarbonyl)piperidine-3-carboxylic acid

Levisoprenaline

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

2,2-[(3-Methoxyphenyl)imino]diethanol

1-Cyclohexyl-5-Oxo-Pyrrolidine-3-Carboxylic Acid

N-Boc Histamine

tert-butyl 3-ethynylmorpholine-4-carboxylate

5-(diethylaminomethyl)-2-methylfuran-3-carboxylic acid

1-cyclopentyl-6-oxopiperidine-3-carboxylic acid

1-(2-HYDROXYETHYL)-4-METHANESULFONYLPIPERAZINE

TERT-BUTYL 2-OXA-3-AZABICYCLO[2.2.2]OCT-5-ENE-3-CARBOXYLATE

1-Benzyl-4,4-difluoropiperidine

C12H15F2N (211.1172)

tert-Butyl(1R,4S)-2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate

Benzenemethanamine, 3,4,5-trimethoxy-a-methyl-,(S)-

4-(3-Methoxypropoxy)-2,3-dimethylpyridine-N-oxide

3-cyclohexyl-4-ethyl-1H-1,2,4-triazole-5-thione

4-[[bis-(2-Hydroxyethyl)amino]methyl]phenol

Benzenemethanamine, 2,3,4-trimethoxy-a-methyl-,(S)-

1-Propanol,2-amino-2-methyl-,benzoate

isolan

N-methyl-N-[4-oxo-4-(2,4,5,6-tetradeuteriopyridin-3-yl)butyl]nitrous amide

C10H9D4N3O2 (211.1259)

Ethyl 3-oxooctahydro-1H-cyclopenta[c]pyridine-4-carboxylate

tert-butyl 6-oxo-3-aza-bicyclo[3.2.0]heptane-3-carboxylate

6-Amino-1,3-dipropyluracil

(S)-TERT-BUTYL 3-CYANOPIPERAZINE-1-CARBOXYLATE

(R)-TERT-BUTYL 3-CYANOPIPERAZINE-1-CARBOXYLATE

N-METHYL-3,4,5-TRIMETHOXYBENZYLAMINE

tert-Butyl 2-cyanopiperazine-1-carboxylate

METHYL 4-CARBAMOYLBICYCLO[2.2.2]OCTANE-1-CARBOXYLATE

Methyl 5-[(diethylamino)methyl]-2-furoate

6-(butylamino)-1,3-dimethylpyrimidine-2,4-dione

2-(Cyclopropylcarbamoyl)cyclohexanecarboxylic acid

2-AMINO-5-BUTYL-6-(METHOXYMETHYL)PYRIMIDIN-4-OL

4-(2-oxopyrrolidin-1-yl)cyclohexane-1-carboxylic acid

Triethanolamineborate

C6H18BNO6 (211.1227)

tert-butyl (2R)-2-cyanopiperazine-1-carboxylate

tert-butyl 3-(4-amino-1H-pyrazol-1-yl)propanoate

cis-7-Oxo-2-aza-bicyclo[3.2.0]heptane-2-carboxylic acid tert-butyl ester

ETHYL5-AMINO-1-TERT-BUTYL-1H-PYRAZOLE-4-CARBOXYLATE

tert-Butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate

TERT-BUTYL 5-OXO-2-AZASPIRO[3.3]HEPTANE-2-CARBOXYLATE

ETHYL5-AMINO-1-TERT-BUTYL-1H-PYRAZOLE-3-CARBOXYLATE

[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methanol

DIETHYLAMINE SALICYLATE

2-(3,4-Difluorophenyl)azepane

C12H15F2N (211.1172)

tert-Butyl 3-amino-3-cyanopyrrolidine-1-carboxylate

DL-BETA-(3,4-DIMETHOXYPHENYL)ALANINOL

Ethyl 2-oxo-4-(2H5)phenylbutanoate

C12H9D5O3 (211.1257)

1-(3-ISOPROPYL-1,2,4-OXADIAZOL-5-YL)PIPERIDIN-4-OL

1-(3-(TRIFLUOROMETHYL)PHENETHYL)HYDRAZINE

m-PEG2-O-Ph-NH2

(+)-Isoproterenol

(S)-orciprenaline

TMPEA

4-13-00-02919 (Beilstein Handbook Reference)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens

[Amino(phenyl)methylidene]-benzylazanium

C14H15N2+ (211.1235)

(9Z)-12-oxo-dodec-9-enoate

12-Oxo-trans-10-dodecenoate

(10Z)-12-oxo-10-dodecenoic acid

(2S,3R,4R)-1-(4-aminophenyl)pentane-2,3,4-triol

(E)-12-oxododec-9-enoate

(R)-orciprenaline

isoproterenol

DL-Isoproterenol

R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CB - Non-selective beta-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AB - Non-selective beta-adrenoreceptor agonists C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CA - Adrenergic and dopaminergic agents D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents

orciprenaline

metaproterenol